Sign in

CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Biomea Fusion, Inc.

Sign in to watch
Ticker
BMEA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 980-9099
Business address
1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
  1. 4 Open-market buy President & COO bought 204,470 shares at an average $16.15 ($3,301,795)
  2. 4 Open-market buy CEO bought 204,470 shares at an average $16.15 ($3,301,795)
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SC 13G Stake Amended Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Regulation FD disclosure
  9. 8-K/A Event Executive or director change
  10. 8-K Event Executive or director change
  11. 8-K Event Executive or director change
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Executive or director change
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13D Stake Beneficial Ownership Report
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy Director bought 900,000 shares at $17.00 ($15,300,000)

Page 13 of 15 · 292 filings